Skip to main content
Log in

Clinimetrics and epilepsy care

  • Articles
  • Published:
Pharmaceutisch Weekblad Aims and scope Submit manuscript

Abstract

In order to study the practicability of rating scales in the regular care of people with epilepsy, indices have been developed and tested on their validity. These indices consist of the Index of Seizures, representing seizure activity, and the Composite Index of Impairment concerning the severity of impairment caused by the seizure type and frequency and the side-effects of anti-epileptic drug treatment. The indices have been applied in a retrospective quantitative evaluation of anti-epileptic drug therapy. The medical records of 250 randomly selected patients registered at an adult out-patient clinic have been reviewed. Their seizures have been classified as generalized tonic-clonic, simple partial and/or complex partial. The distribution of this population according to these indices has been studied, which leads us to the following conclusions:

  • the global indices are valid for clinical application;

  • in 18.6% of the patients studied there was severe impairment and unacceptable seizure control;

  • combined types of seizure are difficult to control;

  • no significant difference is demonstrated between monotherapy and polytherapy regarding the amount of neurotoxicity.

The indices can be determined rapidly and therefore may become valuable aids for the physician in an out-patient clinic to support a decision whether or not to revise current anti-epileptic drug therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Beghi E, Di Mascio R, Tognoni G. Drug treatment of epilepsy. Outlines, criticism and perspectives. Drugs 1986;31:249–65.

    PubMed  Google Scholar 

  2. Feinstein AR. Clinimetrics. New Haven: Yale University Press, 1987.

    Google Scholar 

  3. Cramer JA, Mattson RH, Smith DB, et al. A method of quantification for the evaluation of antiepileptic drug therapy. Neurology 1983;33(Suppl 1):26–37.

    PubMed  Google Scholar 

  4. Mattson RH, Cramer JA, Collins JF, et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic clonic seizures. N Engl J Med 1985;313:145–51.

    PubMed  Google Scholar 

  5. Gowers WR. Epilepsy and other chronic convulsive diseases. London: Churchill, 1881.

    Google Scholar 

  6. Reynolds EH. Iatrogenic disorders in epilepsy. In: Williams D, ed. Modern trends in neurology; vol. 5. London: Butterworth, 1970:271–86.

    Google Scholar 

  7. Rwiza HT, Keyser A, Hekster YA, et al. Retrospective analysis of drug treatment in epileptic patients. Pharm Weekbl [Sci] 1989;11(2):50–5.

    Google Scholar 

  8. Anonymous. WHO-International Classification of impairments, disabilities and handicaps. Geneva: World Health Organization, 1980.

    Google Scholar 

  9. Trimble MR. Chronic epilepsy. Its prognosis and management. Chichester: John Wiley & Sons, 1989.

    Google Scholar 

  10. Meldrum BS. Pathophysiology of chronic epilepsy. In: Trimble MR, ed. Chronic epilepsy. Its prognoses and management. Chichester: John Wiley & Sons, 1989:1–11.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wijsman, D.J.P., Hekster, Y.A., Keyser, A. et al. Clinimetrics and epilepsy care. Pharmaceutisch Weekblad Scientific Edition 13, 182–188 (1991). https://doi.org/10.1007/BF01957744

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01957744

Keywords

Navigation